1. Home
  2. SARO vs RGEN Comparison

SARO vs RGEN Comparison

Compare SARO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SARO
  • RGEN
  • Stock Information
  • Founded
  • SARO 1911
  • RGEN 1981
  • Country
  • SARO United States
  • RGEN United States
  • Employees
  • SARO N/A
  • RGEN N/A
  • Industry
  • SARO
  • RGEN Medical/Dental Instruments
  • Sector
  • SARO
  • RGEN Health Care
  • Exchange
  • SARO NYSE
  • RGEN Nasdaq
  • Market Cap
  • SARO 9.3B
  • RGEN 8.0B
  • IPO Year
  • SARO 2024
  • RGEN N/A
  • Fundamental
  • Price
  • SARO $30.21
  • RGEN $123.26
  • Analyst Decision
  • SARO Buy
  • RGEN Buy
  • Analyst Count
  • SARO 8
  • RGEN 12
  • Target Price
  • SARO $34.75
  • RGEN $172.67
  • AVG Volume (30 Days)
  • SARO 1.7M
  • RGEN 793.9K
  • Earning Date
  • SARO 05-12-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • SARO N/A
  • RGEN N/A
  • EPS Growth
  • SARO N/A
  • RGEN N/A
  • EPS
  • SARO 0.23
  • RGEN N/A
  • Revenue
  • SARO $5,437,026,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • SARO $14.74
  • RGEN $13.93
  • Revenue Next Year
  • SARO $11.20
  • RGEN $14.35
  • P/E Ratio
  • SARO $128.36
  • RGEN N/A
  • Revenue Growth
  • SARO 17.03
  • RGEN 4.88
  • 52 Week Low
  • SARO $21.31
  • RGEN $102.97
  • 52 Week High
  • SARO $34.38
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • SARO N/A
  • RGEN 41.34
  • Support Level
  • SARO N/A
  • RGEN $123.10
  • Resistance Level
  • SARO N/A
  • RGEN $135.47
  • Average True Range (ATR)
  • SARO 0.00
  • RGEN 7.10
  • MACD
  • SARO 0.00
  • RGEN -1.05
  • Stochastic Oscillator
  • SARO 0.00
  • RGEN 5.39

About SARO STANDARDAERO INC.

StandardAero Inc is a provider of aftermarket services for fixed and rotary wing aircraft gas turbine engines and auxiliary power units (APUs) to the commercial, business, and military aircraft markets. It also provides aftermarket and upgrade services for business aviation and helicopter airframes and avionics. It operates in two segments Engine Services and Component Repair Services. The group generates the majority of its revenue from the Engine Services segment which provides engine and airframe maintenance, repair, overhaul, and related services to customers in the Commercial Aerospace, Military & Helicopter, and Business Aviation end markets.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: